M
Maj Brit Nørregaard Kjær
Researcher at University of Copenhagen
Publications - 14
Citations - 389
Maj Brit Nørregaard Kjær is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Medicine & Intensive care unit. The author has an hindex of 5, co-authored 6 publications receiving 84 citations. Previous affiliations of Maj Brit Nørregaard Kjær include Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure
Olav L. Schjørring,Thomas Lass Klitgaard,Anders Perner,Jørn Wetterslev,Theis Lange,Martin Siegemund,Minna Bäcklund,Frederik Keus,Jon Henrik Laake,Matt Morgan,Katrin Thormar,Søren A. Rosborg,Jannie Bisgaard,Annette E.S. Erntgaard,Anne Sofie H. Lynnerup,Rasmus L. Pedersen,Elena Crescioli,Theis C. Gielstrup,Meike T. Behzadi,Lone Musaeus Poulsen,Stine Estrup,Jens Laigaard,Cheme Andersen,Camilla Bekker Mortensen,Björn A. Brand,Jonathan White,Inge Lise Jarnvig,Morten Hylander Møller,Lars Quist,Morten H. Bestle,Martin Schønemann-Lund,Maj K. Kamper,Mathias Hindborg,Alexa Hollinger,Caroline E. Gebhard,Núria Zellweger,Christian S. Meyhoff,Mathias Hjort,Laura K. Bech,Thorbjørn Grøfte,Helle Bundgaard,Lars Ostergaard,Maria A. Thyø,Thomas Hildebrandt,Bülent Uslu,Christoffer Sølling,Nette Møller-Nielsen,Anne Craveiro Brøchner,Morten Borup,Marjatta Okkonen,Willem Dieperink,Ulf Gøttrup Pedersen,Anne Sofie Andreasen,Lone Buus,Tayyba N. Aslam,Robert Winding,Joerg C. Schefold,Stine B. Thorup,Susanne Iversen,Janus Engstrøm,Maj Brit Nørregaard Kjær,Bodil Steen Rasmussen +61 more
TL;DR: In this paper, the benefits and harms of different oxygenation levels for patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) were discussed. But, the benefits of different levels of oxygenation were not evaluated.
Journal ArticleDOI
Restriction of Intravenous Fluid in ICU Patients with Septic Shock.
Tine Sylvest Meyhoff,Peter Buhl Hjortrup,Jørn Wetterslev,Praleene Sivapalan,Jon Henrik Laake,Maria Cronhjort,Stephan M. Jakob,Maurizio Cecconi,Marek Nalos,Marlies Ostermann,Manu L N G Malbrain,Ville Pettilä,Morten Hylander Møller,Maj Brit Nørregaard Kjær,Theis Lange,Christian Overgaard-Steensen,Björn A. Brand,Marie Winther-Olesen,Jonathan White,Lars Quist,B. Westergaard,Andreas Bender Jonsson,Carl Johan Steensen Hjortsø,Nick Meier,Thomas Steen Jensen,Janus Engstrøm,Lars Nebrich,Nina Christine Andersen-Ranberg,Jacob V. Jensen,Neeliya A Joseph,Lone Musaeus Poulsen,Louise S Herløv,Christoffer Sølling,Susan K Pedersen,Kurt Krogh Knudsen,Therese Simonsen Straarup,Marianne L. Vang,Helle Bundgaard,Bodil Steen Rasmussen,S. Aagaard,Thomas B. Hildebrandt,Lene Russell,Morten H. Bestle,Martin Schonemann-Lund,Anne Craveiro Brøchner,Claes Elvander,S Hoffmann,Michael L. Rasmussen,Yvonne K Martin,F Friberg,Herman Seter,Tayyba N. Aslam,Sigrid Ådnøy,Philipp Seidel,Kristian Strand,B. Johnstad,Eva Joelsson-Alm,Jens Christensen,Christian Ahlstedt,Carmen A. Pfortmueller,Martin Siegemund,Massimiliano Greco,Jaroslav Radej,Miroslav Kriz,Doug W Gould,Kathryn M Rowan,Paul R Mouncey,Anders Perner +67 more
TL;DR: Among adult patients with septic shock in the ICU, intravenous fluid restriction did not result in fewer deaths at 90 days than standard intravenousfluid therapy, and days alive and out of the hospital were similar in the two groups.
Journal ArticleDOI
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial.
Anders Granholm,Marie Warrer Munch,Sheila Nainan Myatra,Bharath Kumar Tirupakuzhi Vijayaraghavan,Bharath Kumar Tirupakuzhi Vijayaraghavan,Maria Cronhjort,Rebecka Rubenson Wahlin,Stephan M. Jakob,Luca Cioccari,Maj Brit Nørregaard Kjær,Gitte Kingo Vesterlund,Tine Sylvest Meyhoff,Marie Helleberg,Morten Hylander Møller,Thomas Benfield,Balasubramanian Venkatesh,Naomi E Hammond,Naomi E Hammond,Naomi E Hammond,Sharon Micallef,Abhinav Bassi,Oommen John,Oommen John,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha,Klaus Tjelle Kristiansen,Charlotte Suppli Ulrik,Vibeke Lind Jørgensen,Margit Smitt,Morten H. Bestle,Morten H. Bestle,Anne Sofie Andreasen,Lone Musaeus Poulsen,Bodil Steen Rasmussen,Anne Craveiro Brøchner,Thomas Strøm,Anders Pape Møller,Mohd Saif Khan,Ajay Padmanaban,Jigeeshu V Divatia,Sanjith Saseedharan,Kapil Borawake,Farhad N Kapadia,Subhal Dixit,Rajesh Chawla,Urvi Shukla,Pravin Amin,Michelle S Chew,Christian Aage Wamberg,Christian Gluud,Christian Gluud,Theis Lange,Anders Perner +53 more
TL;DR: In this article, the authors compared dexamethasone 12 versus 6mg daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, randomised, blinded COVID STEROID 2 trial.
Journal ArticleDOI
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan.
Marie Warrer Petersen,Tine Sylvest Meyhoff,Marie Helleberg,Maj Brit Nørregaard Kjær,Anders Granholm,Carl Johan Steensen Hjortsø,Thomas Steen Jensen,Morten Hylander Møller,Peter Buhl Hjortrup,Mik Wetterslev,Gitte Kingo Vesterlund,Lene Russell,Vibeke Lind Jørgensen,Klaus Tjelle,Thomas Benfield,Charlotte Suppli Ulrik,Anne Sofie Andreasen,Thomas Mohr,Morten H. Bestle,Lone Musaeus Poulsen,Mette Friberg Hitz,Thomas Hildebrandt,Lene Surland Knudsen,Anders Pape Møller,Christoffer Sølling,Anne Craveiro Brøchner,Bodil Steen Rasmussen,Henrik Nielsen,Steffen Christensen,Thomas Strøm,Maria Cronhjort,Rebecka Rubenson Wahlin,Stephan M. Jakob,Luca Cioccari,Balasubramanian Venkatesh,Naomi E Hammond,Vivekanand Jha,Vivekanand Jha,Sheila Nainan Myatra,Christian Gluud,Theis Lange,Anders Perner +41 more
TL;DR: Clinical equipoise on the use of corticosteroids for COVID‐19 exists, with mixed effects, including longer time to viral clearance.
Journal ArticleDOI
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial.
Marie Warrer Munch,Tine Sylvest Meyhoff,Marie Helleberg,Maj Brit Nørregaard Kjær,Anders Granholm,Carl Johan Steensen Hjortsø,Thomas Steen Jensen,Morten Hylander Møller,Peter Buhl Hjortrup,Mik Wetterslev,Gitte Kingo Vesterlund,Lene Russell,Vibeke Lind Jørgensen,Klaus Tjelle Kristiansen,Thomas Benfield,Charlotte Suppli Ulrik,Anne Sofie Andreasen,Morten H. Bestle,Morten H. Bestle,Lone Musaeus Poulsen,Thomas Hildebrandt,Lene Surland Knudsen,Anders Pape Møller,Christoffer Sølling,Anne Craveiro Brøchner,Bodil Steen Rasmussen,Henrik Nielsen,Steffen Christensen,Thomas Strøm,Maria Cronhjort,Rebecka Rubenson Wahlin,Stephan M. Jakob,Luca Cioccari,Balasubramanian Venkatesh,Naomi E Hammond,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha,Sheila Nainan Myatra,Marie Qvist Jensen,Jens Wolfgang Leistner,Vibe Sommer Mikkelsen,Jens S. Svenningsen,Signe Bjørn Laursen,Emma Victoria Hatley,Camilla Meno Kristensen,Ali Al-Alak,Esben Clapp,Trine Bak Jonassen,Caroline Løkke Bjerregaard,Niels Christian Haubjerg Østerby,Mette Mindedahl Jespersen,Dalia Abou-Kassem,Mathilde Languille Lassen,Reem Zaabalawi,Mohammed Mahmoud Daoud,Suhayb Abdi,Nick Meier,Kirstine la Cour,Cecilie Bauer Derby,Birka Ravnholt Damlund,Jens Laigaard,Lene Lund Andersen,Johan Mikkelsen,Jeppe Lundholm Stadarfeld Jensen,Anders Hørby Rasmussen,Emil Arnerlöv,Mathilde Lykke,Mikkel Zacharias Bystrup Holst-Hansen,Boris Wied Tøstesen,Janne Schwab,Janne Schwab,Emilie Kabel Madsen,Christian Gluud,Christian Gluud,Theis Lange,Anders Perner +76 more
TL;DR: The COVID STEROID trial as discussed by the authors evaluated the effects of low-dose hydrocortisone on patient-centred outcomes in adults with COVID-19 and severe hypoxia.